Significant expression of IGFBP2 in breast cancer compared with benign lesions. - Wikidata - awgldk - TriplyDB

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

http://www.wikidata.org/entity/Q35588467

about

IGF-Binding Protein 2 - Oncogene or Tumor Suppressor?Insulin-like growth factor system in cancer: novel targeted therapies Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3 Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation.Quantitative analysis of the secretome of TGF-beta signaling-deficient mammary fibroblasts.Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.Differentially regulated splice variants and systems biology analysis of Kaposi's sarcoma-associated herpesvirus-infected lymphatic endothelial cells.Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent.Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells.IGFBP-2 and -5: important regulators of normal and neoplastic mammary gland physiology Insulin-like growth factor binding protein 2 promotes glioma development and progression IGFBP2 potentiates nuclear EGFR-STAT3 signaling.Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer Regulation of protumorigenic pathways by insulin like growth factor binding protein2 and its association along with β-catenin in breast cancer lymph node metastasis.Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease.Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.Genome-wide screening of indicator genes for assessing the potential carcinogenic risk of Nanjing city drinking water.Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells.IGFBP-2 expression in MCF-7 cells is regulated by the PI3K/AKT/mTOR pathway through Sp1-induced increase in transcription.Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma.Silencing IGFBP-2 decreases pancreatic cancer metastasis and enhances chemotherapeutic sensitivity.IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.Adeno-associated virus type 2-mediated gene transfer of a short hairpin-RNA targeting human IGFBP-2 suppresses the proliferation and invasion of MDA-MB-468 cells.Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies.

P2860

Q27003443-40C208E9-55B3-40DE-8C5D-5E4438AFF4C9 Q28081603-3A74F06E-B8B9-48C1-B1FB-3537F84AD748 Q28484376-11A7EEDF-FA6F-4B00-9969-D89AE0AF4786 Q29417100-7414BEA5-262F-44F9-9FC5-1A9A49AFFC1F Q30975797-1C9A07BA-C7E8-4A67-BEB6-B07637AAF197 Q31111254-0EBB9B1E-4A47-4965-8D54-621DB0A8BD72 Q33349898-BCB5017F-400D-45F6-868B-FF93ACC6D1E8 Q33745176-3B88712C-AA42-43D3-97DA-43BD0AFA1A0B Q33869094-534B2F6E-351F-40B5-8A82-3077CA2782BD Q34145178-0C7EB5D0-EA33-46BE-99F5-709D60829605 Q34391968-C054BA14-8C62-4B8B-B448-87C8BB4875B7 Q34999407-4638E347-BD6A-4C78-A8EB-2CC33BAD7E4C Q35198402-CE39E6A6-F5AD-46F5-A13E-22225394E75F Q35524233-B18E1C79-70CC-4A0D-986C-47F9035AD1C3 Q35621452-F881EF7C-D7B8-4863-95CD-7F6241243CFD Q35690638-1C137FE1-4E8B-47F7-B34B-18054BACCFEB Q35880328-6BFB1399-D42D-49B0-82BF-7810D424014A Q36189855-8C909D2F-0E09-437D-BFE8-CA668E7DECF9 Q36642867-18E779E4-308B-47AE-9296-DAE00D4403F2 Q36972353-C25A4D60-864E-452B-8B77-FDABA5093C5A Q37001399-2F43A817-6E07-4B29-A3AA-AF5BF72FB213 Q37348411-E3D86DE8-412C-479C-8309-8D816AFA861E Q37362627-D8BFC2EC-3D99-4E30-A8A0-20BA658D474B Q37395331-D5C7BD30-7BE2-4466-B45A-725D900CC5D3 Q37396281-049635A3-77E2-440D-A4D1-0E23BDBB5C80 Q37418923-297A3603-C27A-4EC6-925D-0000E281FFA3 Q37720601-6964E8D2-3129-4D3C-97EA-24D5792C10D5 Q38302138-97F000C6-9802-4CB1-8DA4-EC39BB8ABEF5 Q38502919-3EA07F19-8B6E-4DA5-97D8-A9F669C06FE9 Q38586626-BA1A76B5-E082-4841-8DF8-1C56D54B7043 Q39189621-A6A113CD-9A08-4D98-93D8-B5C395C06E93 Q39718565-8199EC24-9577-4672-A637-EE4B7F2B77F8 Q41696965-C8567515-198D-406D-9BC2-70B021614944 Q42365291-4C67C763-529D-4EE0-8F94-6953BFD2DEC8 Q46676464-F09979AA-612B-49B7-9DAA-D16D9084E7CC Q47552079-215CBE59-0BDC-4996-812F-C0490CF6DD1A Q52598780-1A74BE1E-35E7-4174-9410-49B00185DC85 Q55462258-4DCCD445-4548-49E7-910C-96AF90F1E567

P2860

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

http://www.wikidata.org/entity/Q35588467

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

@ast

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

@en

type

label

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

@ast

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

@en

prefLabel

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

@ast

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

@en

P1433

Q35588467-33E07AE4-1ECB-4C88-B432-9A595858692C

P1476

Q35588467-F9C105A7-AB45-4D71-8005-D67E213637DC

P2093

Q35588467-13A534AE-5AA0-4AC9-A2FB-E9BE2DE727BC

Q35588467-6CE0B36B-980B-4421-BA13-3E016FC4EA83

Q35588467-95029BF0-7084-44D3-A646-E0CAF919E579

Q35588467-9DE86012-9CE1-49D9-9FB0-9FF9FE62A6B9

Q35588467-A00E1ECC-5562-437D-B787-63A61841C4E9

Q35588467-DFAC9A85-5816-4736-B05A-359C916B754A

Q35588467-EAE81A69-036B-47EC-9608-5B825DA35AC4

P2860

Q35588467-0E02809C-87F5-4F77-82DA-409247EF0619

Q35588467-1AC77B42-718C-4D89-9D25-244355DF02AB

Q35588467-1F589DF7-58DE-46CE-9B59-709304A02395

Q35588467-2A08F618-8F14-4DAB-82A6-D2891B5923AF

Q35588467-349F23BF-19F7-4C64-9118-6C13BE283860

Q35588467-70C5BDC6-6135-4B84-9F85-BE4D6D3CE998

Q35588467-9245159C-C383-4E77-812C-98621F2409B6

Q35588467-94033188-0209-4740-AB33-3D801C6D4652

Q35588467-C53BF9C8-DDF5-44A4-87C0-3628027AD576

Q35588467-C8E281D1-55EC-4885-B02E-9F0D4514FF19

P304

Q35588467-AF99B41F-2A61-4F72-BFE8-FEA5813AA451

P31

Q35588467-E11903E1-2B3E-4D1B-9664-7635D6F3C46B

P356

Q35588467-E09D4575-756B-4FB3-AFF0-B92BBF7B8F32

P407

Q35588467-3FC2EEEC-50A9-4FFD-B3EE-68F6B16D014A

P433

Q35588467-3144FA4C-FB4A-44D5-B462-113384137F50

P478

Q35588467-7675C2A2-48C2-444B-91F4-152BF211A832

P577

Q35588467-5F6B7D46-946F-4AF1-89F5-EAF4FC73E74D

P5875

Q35588467-DD05B3DA-65C9-445F-BEFB-E054C2D327E6

P698

Q35588467-DE8522AB-32C0-4183-A089-2BCB1E10EC68

P932

Q35588467-AC11954A-E6B7-441D-9DD4-05B8C802D8F0

P356

JCP.2004.020834

P1433

Journal of Clinical Pathology

P1476

Significant expression of IGFBP2 in breast cancer compared with benign lesions.

@en

P2093

C Busch

http://www.w3.org/2001/XMLSchema#string

E Richardsen

http://www.w3.org/2001/XMLSchema#string

H Stalsberg

http://www.w3.org/2001/XMLSchema#string

L-T Busund

http://www.w3.org/2001/XMLSchema#string

R Busund

http://www.w3.org/2001/XMLSchema#string

T Bjørnsen

http://www.w3.org/2001/XMLSchema#string

T Ukkonen

http://www.w3.org/2001/XMLSchema#string

P2860

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

The characterization and expression of ovine insulin-like growth factor-binding protein-2.

Insulin-like growth factor expression in breast cancer epithelium and stroma.

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.

The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors.

Pathophysiological and clinical aspects of the insulin-like growth factors.

Targeted disruption of IGFBP-2 gene.

Video image analysis in pathology.

Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status.

The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells.

P304

361-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.2004.020834

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7944630

http://www.w3.org/2001/XMLSchema#string

P698

15790698

http://www.w3.org/2001/XMLSchema#string

P932

1770626

http://www.w3.org/2001/XMLSchema#string